How Big Pharma is fighting a Biden program to lower seniors' drug costs
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Stay updated with breaking news from Yaakov Roth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
TRENTON, N.J. - Pharmaceutical giants are mounting a vigorous legal battle against President Biden’s plan to lower seniors’ prescription drug costs, urging federal judges here and around the country to invalidate a new program that aims to reduce the price of medications for high blood pressure, heart disease, cancer and diabetes. In a flurry of lawsuits, these drugmakers have blasted the government initiative as unconstitutional, defended their pricing practices and warned that regulation could
Sen. Menendez alleges that the"zeal to get back" at him led to illegal searches at his home in a motion to suppress search warrant returns.